Back to User profile » Dr Jianbing Wu
Papers published by Dr Jianbing Wu:
Original Research
Lenvatinib Plus PD-1 Inhibitors versus Regorafenib in Patients with Advanced Hepatocellular Carcinoma After the Failure of Sorafenib: A Retrospective Study
Xu Y, Fu S, Liu K, Mao Y, Wu J
Therapeutics and Clinical Risk Management 2023, 19:853-863
Published Date: 24 October 2023
Original Research
Efficacy and Safety of Regorafenib with or without PD-1 Inhibitors as Second-Line Therapy for Advanced Hepatocellular Carcinoma in Real-World Clinical Practice
Liu K, Wu J, Xu Y, Li D, Huang S, Mao Y
OncoTargets and Therapy 2022, 15:1079-1094
Published Date: 1 October 2022
Original Research
Efficacy and safety of TACE in combination with sorafenib for the treatment of TACE-refractory advanced hepatocellular carcinoma in Chinese patients: a retrospective study
Wu J, Li A, Yang J, Lu Y, Li J
OncoTargets and Therapy 2017, 10:2761-2768
Published Date: 29 May 2017